# OnCo record triptorelin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/triptorelin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "triptorelin" ;
  schema:name "Triptorelin"@en ;
  schema:alternateName "Decapeptyl"@en, "Triptodur (paediatric)"@en, "Trelstar" ;
  schema:description "Triptorelin (Trelstar) is a one-, three- or six-monthly injection that switches off testosterone production for men with advanced prostate cancer."@en ;
  schema:url <https://onco.cc/drugs/triptorelin/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Triptorelin> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=triptorelin>, <https://www.cancer.gov/about-cancer/treatment/drugs/triptorelin-pamoate> ;
  onco:status "approved" ;
  onco:tag "nci-list" ;
  onco:modality "GnRH agonist depot" ;
  onco:approval "US 2000: Palliative treatment of advanced prostate cancer" ;
  onco:related <https://onco.cc/drugs/leuprolide/>, <https://onco.cc/drugs/goserelin/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:companies <https://onco.cc/companies/verity-pharma/>, <https://onco.cc/companies/ipsen/> ;
  onco:trials <https://onco.cc/trials/nct00066703/>, <https://onco.cc/trials/nct01020448/>, <https://onco.cc/trials/nct00412022/> .